Medpace Holdings, Inc.'s functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.
| Comparison | MEDP peer score | |
|---|---|---|
|
Medpace Holdings, Inc. vs Neurocrine Biosciences, Inc.
|
56 | Compare → |
|
Medpace Holdings, Inc. vs Penumbra, Inc.
|
52 | Compare → |
|
Medpace Holdings, Inc. vs Fielmann Group AG
|
68 | Compare → |
|
Medpace Holdings, Inc. vs IDEXX Laboratories, Inc.
|
70 | Compare → |
|
Medpace Holdings, Inc. vs SharkNinja, Inc.
|
61 | Compare → |
|
Medpace Holdings, Inc. vs Deckers Outdoor Corporation
|
76 | Compare → |
|
Medpace Holdings, Inc. vs Comfort Systems USA, Inc.
|
66 | Compare → |
|
Medpace Holdings, Inc. vs RENK Group AG
|
39 | Compare → |
|
Medpace Holdings, Inc. vs Accelleron Industries AG
|
67 | Compare → |
|
Medpace Holdings, Inc. vs Garmin Ltd.
|
56 | Compare → |
|
Medpace Holdings, Inc. vs Diploma PLC
|
38 | Compare → |
View the complete Medpace Holdings, Inc. report including all peer dimensions.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.